📣 VHIO will be the new Chair of @EurOPDX, as presented during the annual meeting celebrated in Paris, where we have discussed and presented the latest advances in Patient-Derived Models.
Goretti Mallorquí has taken over as the new EurOPDX manager. Thank you, @MaxVBorsani and @seedingscience for your commitment and work during all these years!
Not heard about our 3rd Workshop in June yet?
It's your lucky day! Registration and abstract submission deadline is extended by 1 week, til 27 May.
Don't wait any longer to register and start preparing your abstract to share your work using patient-derived models in oncology.
The @EJPRareDiseases ERN Research Mobility Fellowship will open next week! You can read project descriptions and personal statements from previous fellows!
Date of launch: 2 May
Past fellows testimonials: https://t.co/o6xGczBM1o
Finally out! In this paper, published in @CRC_AACR,
first authored by Daniel Massó-Vallés, we show that MYC inhibition by Omomyc both prevents and halts disease progression in metastatic breast cancer. @VHIO and @peptomyc. Really proud of Daniel and team. https://t.co/BvlmfN0sSu
It's time to ensure #RareCancers get the attention they deserve!
Thank you @wef for raising awareness on that essential topic with us.
WEF article: https://t.co/Q9lYm3v4FW
More on EORTC's work to tacle rare cancers: https://t.co/7ZFhj0K6e8
#LeavingNoCancerPatientBehind
📣Do you want to help characterizing specific commonalities amongst a large group of “disregarded” rare diseases?
Apply for the new @irdirc Task Force!
🚨 Application deadline: 11 February
ℹ️More information: https://t.co/GVbfQzjpmc
Phenomenal paper just published in Science persuasively demonstrating that EBV causes most if not all multiple sclerosis.
Phenomenal epidemiological design and technical achievement. 👏
https://t.co/LcNFvKHiUp
Treatment landscape for pts with HER2+ mBC is rapidly evolving 📈
📢 check our review on how we treat
📌 just out @ESMO_Open@myESMO@OncoAlert#bcsm
👉 https://t.co/p3u9kjcZby
🥳SAVE THE DATE🥳
3rd EurOPDX Workshop to be held at the Hotel Zuiderduin (Egmond aan Zee, NL) on 27-29 June 2022!
We can't wait to have an in-person meeting again with the community after all these years!
See u there!
Following decades of human and #AnimalResearch the @WHO has approved a roll out of the RTS,S #MalariaVaccine for children across most of Africa.
"Having a vaccine - after more than a century of trying - is among medicine's greatest achievements."
https://t.co/Gr4M5spde0
Pour les 30 ans de la Fête de la Science @FeteScience et l'« Année de la biologie au @CNRS», les unités de « Physico-Chimie » et de « Biologie Cellulaire et Cancer » de l'@institut_curie vous accueillent. Demandez le programme ! https://t.co/VVGJKaArrA
📣 Abrimos la primera convocatoria de becas institucionales para investigadores predoctorales. Únete a nuestro equipo❗️
➕ https://t.co/br2yLG6sQZ
#PhDFellowshipsCall